Our bi-weekly watchlist AKA “Trade Insights,” is an email sent to our members on Sunday and Wednesday night which includes:
Monthly, and quarterly subscriptions offer the same access. The difference between these subscriptions is the billing schedule. Monthly is billed once per month, quarterly is billed once every 3 months. Quarterly subscriptions offer a discount compared to the monthly subscription.
Yes, all subscription options offer a free trial. We want to make sure our service is good fit for you!
Yes. Once subscribed you can manage your subscription under your profile. Here you will find the option to pause or cancel your subscription. We just ask that you provide some feedback if your willing to help us improve.
MS Money Move and its Chief Operating Officer who is a scientist and individual investor, as well as its affiliates are not registered financial advisors. Our posts should serve as educational material to help you conduct due diligence research. Posts and articles are not directives or recommendations to invest in any security. We reserve the right to buy or sell any security for ourselves without any notification except when required by law. We are not responsible for the action of our affiliates. Investment theses may change due to the variable nature of the securities market. Because of this there is great risk when investing in stocks and options which can result is capital loss. Additionally, past performance by MS Money Moves or any security is not a predictor of future performance. Everyone should conduct their own research and due diligence before making an investment decision. We recommend you consult a financial advisor regarding any investment action.
The biotech sector is especially volatile. Stock prices may fluctuate substantially based on material or nonmaterial developments. We encourage everyone to familiarize themselves with clinical trial processes, relevant terminology, FDA/SEC rules and regulations, and the general processes of drug & therapy development/approval. Always do independent research in a security prior to investing.